National Health Investors, Inc. (NYSE:NHI) had its price target increased by investment analysts at Stifel Nicolaus from $80.00 to $82.00 in a research note issued on Wednesday, Marketbeat.com reports. The brokerage currently has a “buy” rating on the real estate investment trust’s stock. Stifel Nicolaus’ target price points to a potential upside of 4.37% from the company’s current price.

Several other research analysts have also commented on NHI. ValuEngine lowered shares of National Health Investors from a “buy” rating to a “hold” rating in a research note on Tuesday, June 13th. Cantor Fitzgerald reissued a “neutral” rating and issued a $75.00 price objective on shares of National Health Investors in a research note on Tuesday, February 21st. Zacks Investment Research downgraded shares of National Health Investors from a “buy” rating to a “hold” rating in a research note on Tuesday, May 16th. Finally, Bank of America Corporation downgraded shares of National Health Investors from a “neutral” rating to an “underperform” rating and set a $76.00 price target for the company. in a research note on Monday, May 22nd. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and two have issued a buy rating to the company’s stock. The stock has an average rating of “Hold” and an average target price of $79.17.

Analyst Recommendations for National Health Investors (NYSE:NHI)

National Health Investors (NYSE NHI) traded up 0.08% during midday trading on Wednesday, hitting $78.57. 666,249 shares of the stock traded hands. The firm has a market cap of $3.22 billion, a P/E ratio of 19.08 and a beta of 0.60. The company’s 50-day moving average is $75.67 and its 200 day moving average is $74.03. National Health Investors has a 12-month low of $66.31 and a 12-month high of $82.53.

National Health Investors (NYSE:NHI) last posted its quarterly earnings data on Tuesday, May 9th. The real estate investment trust reported $1.10 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $1.26 by $0.16. National Health Investors had a net margin of 63.72% and a return on equity of 13.36%. The business had revenue of $66.39 million during the quarter, compared to analysts’ expectations of $65.42 million. During the same period in the previous year, the business posted $1.16 EPS. The company’s revenue for the quarter was up 12.5% compared to the same quarter last year. On average, analysts anticipate that National Health Investors will post $3.73 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Thursday, August 10th. Investors of record on Friday, June 30th will be paid a $0.95 dividend. The ex-dividend date of this dividend is Wednesday, June 28th. This represents a $3.80 dividend on an annualized basis and a yield of 4.84%. National Health Investors’s dividend payout ratio is currently 92.23%.

ILLEGAL ACTIVITY NOTICE: This piece of content was published by American Banking News and is the sole property of of American Banking News. If you are accessing this piece of content on another publication, it was illegally copied and reposted in violation of United States and international copyright laws. The correct version of this piece of content can be read at https://www.americanbankingnews.com/2017/06/25/national-health-investors-inc-nhi-price-target-increased-to-82-00-by-analysts-at-stifel-nicolaus.html.

Hedge funds and other institutional investors have recently modified their holdings of the company. Norges Bank purchased a new position in shares of National Health Investors during the fourth quarter worth about $28,878,000. Ladenburg Thalmann Financial Services Inc. increased its position in shares of National Health Investors by 6.8% in the fourth quarter. Ladenburg Thalmann Financial Services Inc. now owns 2,861 shares of the real estate investment trust’s stock worth $212,000 after buying an additional 182 shares in the last quarter. Guggenheim Capital LLC increased its position in shares of National Health Investors by 130.7% in the fourth quarter. Guggenheim Capital LLC now owns 65,111 shares of the real estate investment trust’s stock worth $4,829,000 after buying an additional 36,885 shares in the last quarter. A.R.T. Advisors LLC purchased a new position in shares of National Health Investors during the fourth quarter worth about $674,000. Finally, New York State Teachers Retirement System increased its position in shares of National Health Investors by 3.1% in the fourth quarter. New York State Teachers Retirement System now owns 3,300 shares of the real estate investment trust’s stock worth $245,000 after buying an additional 100 shares in the last quarter. Institutional investors own 69.51% of the company’s stock.

About National Health Investors

National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.

Receive News & Ratings for National Health Investors Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors Inc. and related companies with MarketBeat.com's FREE daily email newsletter.